BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34939517)

  • 21. Elucidation of conserved multi-epitope vaccine against
    Dikhit MR; Sen A
    J Biomol Struct Dyn; 2024; 42(3):1293-1306. PubMed ID: 37054523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reverse engineering protection: A comprehensive survey of reverse vaccinology-based vaccines targeting viral pathogens.
    Ponne S; Kumar R; Vanmathi SM; Brilhante RSN; Kumar CR
    Vaccine; 2024 Apr; 42(10):2503-2518. PubMed ID: 38523003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoinformatic based designing of potential immunogenic novel mRNA and peptide-based prophylactic vaccines against H5N1 and H7N9 avian influenza viruses.
    Ghafoor D; Zeb A; Ali SS; Ali M; Akbar F; Ud Din Z; Ur Rehman S; Suleman M; Khan W
    J Biomol Struct Dyn; 2024 Apr; 42(7):3641-3658. PubMed ID: 37222664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Designing of cytotoxic T lymphocyte-based multi-epitope vaccine against SARS-CoV2: a reverse vaccinology approach.
    Vivekanandam R; Rajagopalan K; Jeevanandam M; Ganesan H; Jagannathan V; Selvan Christyraj JD; Kalimuthu K; Selvan Christyraj JRS; Mohan M
    J Biomol Struct Dyn; 2022; 40(24):13711-13726. PubMed ID: 34696708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pan-genome and reverse vaccinology approaches to design multi-epitope vaccine against Epstein-Barr virus associated with colorectal cancer.
    Priyamvada P; Ramaiah S
    Immunol Res; 2023 Dec; 71(6):887-908. PubMed ID: 37423939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reverse vaccinology and subtractive genomics-based putative vaccine targets identification for Burkholderia pseudomallei Bp1651.
    Hizbullah ; Nazir Z; Afridi SG; Shah M; Shams S; Khan A
    Microb Pathog; 2018 Dec; 125():219-229. PubMed ID: 30243554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza.
    Russo G; Crispino E; Maleki A; Di Salvatore V; Stanco F; Pappalardo F
    BMC Bioinformatics; 2023 Jun; 24(1):231. PubMed ID: 37271819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach.
    Alizadeh M; Amini-Khoei H; Tahmasebian S; Ghatrehsamani M; Ghatreh Samani K; Edalatpanah Y; Rostampur S; Salehi M; Ghasemi-Dehnoo M; Azadegan-Dehkordi F; Sanami S; Bagheri N
    Sci Rep; 2022 May; 12(1):7757. PubMed ID: 35545650
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Ali MC; Khatun MS; Jahan SI; Das R; Munni YA; Rahman MM; Dash R
    J Biomol Struct Dyn; 2022; 40(21):10696-10714. PubMed ID: 36529187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pan genome based reverse vaccinology approach to explore Enterococcus faecium (VRE) strains for identification of novel multi-epitopes vaccine candidate.
    Alotaibi G; Khan K; Al Mouslem AK; Ahmad Khan S; Naseer Abbas M; Abbas M; Ali Shah S; Jalal K
    Immunobiology; 2022 May; 227(3):152221. PubMed ID: 35483110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus.
    Hasan M; Ghosh PP; Azim KF; Mukta S; Abir RA; Nahar J; Hasan Khan MM
    Microb Pathog; 2019 May; 130():19-37. PubMed ID: 30822457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
    Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
    Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Designing a multi-epitope vaccine against Chlamydia pneumoniae by integrating the core proteomics, subtractive proteomics and reverse vaccinology-based immunoinformatics approaches.
    Noor F; Ahmad S; Saleem M; Alshaya H; Qasim M; Rehman A; Ehsan H; Talib N; Saleem H; Bin Jardan YA; Aslam S
    Comput Biol Med; 2022 Jun; 145():105507. PubMed ID: 35429833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-cell and T-cell epitope identification with stability analysis of AI-2 import ATP-binding cassette LsrA from S. typhiIn silico approach.
    Vijayababu P; Samykannu G; Antonyraj CB; Narayanan S; Basheer Ahamed SI; Perumal P; Piramanayagam S
    Microb Pathog; 2018 Oct; 123():487-495. PubMed ID: 30098402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A computational quest for identifying potential vaccine candidates against
    Ullah A; Ul Haq M; Iqbal M; Irfan M; Khan S; Muhammad R; Ullah A; Khurram M; Alharbi M; Alasmari AF; Ahmad S
    J Biomol Struct Dyn; 2024 Apr; 42(6):2976-2989. PubMed ID: 37177816
    [No Abstract]   [Full Text] [Related]  

  • 36. In Silico Characterization of B Cell and T Cell Epitopes for Subunit Vaccine Design of Salmonella typhi PgtE: A Molecular Dynamics Simulation Approach.
    Samykannu G; Vijayababu P; Antonyraj CB; Perumal P; Narayanan S; Basheer Ahamed SI; Natarajan J
    J Comput Biol; 2019 Feb; 26(2):105-116. PubMed ID: 30547672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Putative novel outer membrane antigens multi-epitope DNA vaccine candidates identified by Immunoinformatic approaches to control Acinetobacter baumannii.
    Tabibpour NS; Doosti A; Sharifzadeh A
    BMC Immunol; 2023 Nov; 24(1):46. PubMed ID: 37980458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reverse vaccinology assisted design of a novel multi-epitope vaccine to target Wuchereria bancrofti cystatin: An immunoinformatics approach.
    Das NC; Gupta PSS; Panda SK; Rana MK; Mukherjee S
    Int Immunopharmacol; 2023 Feb; 115():109639. PubMed ID: 36586276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Designing a multi-epitope vaccine for cross-protection against Shigella spp: An immunoinformatics and structural vaccinology study.
    Nosrati M; Hajizade A; Nazarian S; Amani J; Namvar Vansofla A; Tarverdizadeh Y
    Mol Immunol; 2019 Dec; 116():106-116. PubMed ID: 31634814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico designing a novel TLR4-mediating multiepitope vaccine against monkeypox
    Lahimchi MR; Madanchi H; Ahmadi K; Shahbazi B; Yousefi B
    J Biomol Struct Dyn; 2024; 42(4):2094-2110. PubMed ID: 37129119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.